Guj. Themis Bio.

58
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
387.25
18.4 (4.99%)
BSENSE

May 25

BSE+NSE Vol: 7.94 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024

Compare Profit and Loss Results of Guj. Themis Bio.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
835.00
-685.00
-82.04%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
52.00
-52.00
-100.00%
Net Sales
150.00
782.00
-632.00
-80.82%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-64.00
63.00
98.44%
Raw Materials Consumed
25.00
500.00
-475.00
-95.00%
Power & Fuel Cost
26.00
56.00
-30.00
-53.57%
Employee Cost
11.00
80.00
-69.00
-86.25%
Operating Expenses
8.00
29.00
-21.00
-72.41%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
13.00
-13.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
2.00
2.00
100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
81.00
642.00
-561.00
-87.38%
Operating Profit (PBDIT) excl Other Income
69.00
139.00
-70.00
-50.36%
Other Income
1.00
6.00
-5.00
-83.33%
Operating Profit (PBDIT)
71.00
146.00
-75.00
-51.37%
Interest
0.00
18.00
-18.00
-100.00%
Profit before Depriciation and Tax
70.00
127.00
-57.00
-44.88%
Depreciation
5.00
34.00
-29.00
-85.29%
Profit Before Taxation & Exceptional Items
65.00
93.00
-28.00
-30.11%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
65.00
93.00
-28.00
-30.11%
Provision for Tax
16.00
24.00
-8.00
-33.33%
Profit After Tax
48.00
68.00
-20.00
-29.41%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
191.00
359.00
-168.00
-46.80%
Profit Available for appropriations
240.00
427.00
-187.00
-43.79%
Appropriations
240.00
427.00
-187.00
-43.79%
Equity Dividend (%)
67%
40%
27.00
Earnings Per Share
4.48
8.07
-3.59
-44.49%
Profit And Loss - Net Sales
Net Sales 150.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.20% vs 14.45% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.60% vs 6.93% in Mar 2024

Profit And Loss - Interest
Interest 0.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 58.81% vs 30.08% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 48.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -17.56% vs 2.06% in Mar 2024